About
Technology
Issues
FAQ
Links
Official Page
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.